Astra, Sanofi RSV Drug Approved in US for Use in Infants
AstraZeneca Plc and Sanofi’s drug for RSV in infants was approved in the US, the first-ever preventive intended
2023-07-18 01:24
Lilly Applies for Alzheimer’s Drug’s US Approval After Trial Success
Eli Lilly & Co. said it applied for full US approval of its Alzheimer’s disease drug that’s expected
2023-07-17 22:51
Russia seizes control of Danone and Carlsberg operations
Under a new order, the Danone and Carslberg units have been put in "temporary management" of the state.
2023-07-17 11:15
Barcelona & Real Madrid dealt major Financial Fair Play blow by UEFA
UEFA have deemed that Barcelona and Real Madrid must count sales of future revenue streams as debt in their financial records.
2023-07-16 03:22
Pfizer’s $43 Billion Seagen Takeover Faces EU Investigation
Pfizer Inc.’s proposed $43 billion takeover of Seagen Inc. will face an investigation from the European Union’s merger
2023-07-15 15:59
Pfizer’s $43 Billion Seagen Takeover Faces FTC Scrutiny
Pfizer Inc.’s proposed $43 billion takeover of Seagen Inc. will undergo an in-depth antitrust review by the Federal
2023-07-15 06:25
Merger-Arbitrage Funds See Tide Turning After FTC’s Microsoft-Activision Loss
Merger-arbitrage investors say the tide is turning in their favor after the Biden administration’s antitrust push suffered a
2023-07-15 04:27
Lilly to Pay Up to $2 Billion for Obesity Startup Versanis
Eli Lilly & Co. will acquire closely held Versanis Bio, a startup developing a drug for obesity and
2023-07-14 23:27
CapVest to Buy UK Software Provider Kerridge in $1 Billion Deal
Private equity firm CapVest Partners has agreed to acquire UK software provider Kerridge Commercial Systems Ltd. CapVest is
2023-07-13 13:29
Real Madrid scrutinised over unexplained financial losses
Real Madrid potentially face sanctions over unexplained costs of €122m in their latest financial reports.
2023-07-13 00:25
Broadcom Megabond Inches Closer as Firm Seals EU Merger Nod
Broadcom Inc. is moving closer to selling a potential jumbo investment-grade bond after scoring approval from the European
2023-07-12 22:57
Illumina Hit With €432 Million EU Fine for Hasty Grail Deal
Illumina Inc. was hit with a €432 million ($476 million) fine for acquiring cancer-test provider Grail Inc. before
2023-07-12 18:55